XML 17 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Statements of Income - USD ($)
12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2014
Revenue      
Product sales $ 24,410,391 $ 29,894,045 $ 25,512,028
Contract research and development 3,306,887 690,043 422,879
Total revenue 27,717,278 30,584,088 25,934,907
Cost of sales 6,616,852 6,019,868 5,720,277
Gross profit 21,100,426 24,564,220 20,214,630
Expenses      
Selling, general, and administrative 1,752,962 2,312,076 2,235,475
Research and development 3,061,184 3,000,193 3,585,339
Total expenses 4,814,146 5,312,269 5,820,814
Income from operations 16,286,280 19,251,951 14,393,816
Interest income 1,890,817 2,187,723 2,122,133
Income before taxes 18,177,097 21,439,674 16,515,949
Provision for income taxes 5,884,782 7,071,320 5,380,074
Net income $ 12,292,315 $ 14,368,354 $ 11,135,875
Net income per share – basic (in dollars per share) $ 2.53 $ 2.96 $ 2.30
Net income per share – diluted (in dollars per share) 2.53 2.95 $ 2.29
Cash dividends declared per common share (in dollars per share) $ 4 $ 2.06
Weighted average shares outstanding      
Basic (in shares) 4,850,209 4,855,504 4,851,460
Diluted (in shares) 4,852,602 4,871,935 4,867,691